Pharco Corp.

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

IN VITRO DIAGNOSTICS Mergers & Acquisitions PDI Inc. Interpace Diagnostics LLC RedPath Integrated Pathology Inc. PDI Inc. acquired molecular diagnostics company RedPath Integrated Pathology Inc.

Financings Fourth-quarter 2014 biopharma financings reached $8.8 billion, a bump up of 54% over Q3’s $5.7 billion. Q4 was the second-largest of the year (behind Q1’s $9.8 billion) in dollars raised –